drugset / Trial / NCT05700916

Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity

NCT05700916 ↗

RandomizedParallel-groupDouble-blindPrevention

Summary

The major objective of this project is to examine whether daily consumption of milk polar lipids (MPLs) influences cardiometabolic risk factors.

Timeline

Start
2023-10-20
Primary completion
2026-05
Completion
2026-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Milk Polar Lipid-Rich Dairy Powder Unknown 50 g Oral